Capecitabine plus rofecoxib show no activity in patients with metastatic neuroendocrine tumours [6]

Clinical Oncology

Volumn 18, Issue 1, 2006, Pages 88-89

  Krazyzanowska, M K ^a   Tsao, M S ^a   Oza, A M ^a   Haider, M ^a   Feld, R ^a   Knox, J ^a   Chin, S ^a   Hu, H ^a   Siu, L L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CYCLOOXYGENASE 2; ROFECOXIB;

ADULT; ARTERY THROMBOSIS; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; FATIGUE; FEMALE; HAND FOOT SYNDROME; HUMAN; HUMAN TISSUE; LETTER; LIVER METASTASIS; LUNG METASTASIS; MALE; NAUSEA; NEUROENDOCRINE TUMOR; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIMETABOLITES, ANTINEOPLASTIC; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DEOXYCYTIDINE; DRUG THERAPY, COMBINATION; HUMANS; LACTONES; MIDDLE AGED; NEUROENDOCRINE TUMORS; SULFONES;

EID: 30344434371     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2005.08.012     Document Type: Letter

References (5)

1. A. Chaudhry K. Funa K. Oberg Expression of growth factor peptides and their receptors in neuroendocrine tumours of the digestive system Acta Oncol 32 1993 107-114
2. A. Chaudhry K. Oberg A. Gobl C.H. Heldin K. Funa Expression of transforming growth factors beta 1, beta 2, beta 3 in neuroendocrine tumours of the digestive system Anticancer Res 14 1994 2085-2091
3. K.M. Detjen M. Welzel B. Wiedenmann S. Rosewicz Nonsteroidal anti-inflammatory drugs inhibit growth of human neuroendocrine tumour cells via G1 cell-cycle arrest Int J Cancer 107 2003 844-853
4. H.J. Andreyev P. Scott-Mackie D. Cunningham et al. Phase II study of continuous infusion fluorouracil and interferon alfa-2b in the palliation of malignant neuroendocrine tumours J Clin Oncol 13 1995 1486-1492
5. P.M. Hoff R. Ansari G. Batist et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study J Clin Oncol 19 2001 2282-2292